China
Black Ant, GenBridge lead Series B for China coffee chain
M Stand - a China-based coffee shop chain with ambitions to become the Starbucks for China's younger generation - has raised RMB500 million ($77 million) in Series B funding led by Black Ant Capital and GenBridge Capital.
Ince hits $450m first close on second China VC fund
Ince Capital, a Chinese venture capital firm established by J.P. Gan, formerly a managing partner at Qiming Venture Partners, has achieved a first close of approximately $450 million on its second fund.
China beauty: Service with a smile
Beauty and wellness are at the vanguard of China’s fast-rising services sector. Investors see clear paths to growth, but size presents a plethora of problems in terms of standardizing service quality
Deal focus: Neiwai realizes value offline
Vertex Ventures China was adamant that Neiwai should expand offline on leading a Series B for the lingerie brand in 2017. Four years and two rounds later, the strategy is paying off
Capital Today leads $35m Series B for China's XYZ Robotics
Capital Today China Group has led a $35 million Series B round for XYZ Robotics, a Chinese start-up specializing in robotic hand-eye coordination.
PatPat raises $510m across Series C, D rounds
PatPat, a Chinese-founded children’s wear brand that claims to be the world’s largest direct-to-consumer (DTC) player in its segment, has raised $510 million across two rounds of funding.
China's Meiwei Dental raises $150m
China’s Meiwei Dental Group has raised a RMB1 billion ($150 million) Series B round from Fortune Capital, TFTR Investment, and local conglomerate New Hope Group.
Tech investment surges in India, SE Asia as China plummets
A drop-off in PE and VC technology investment in China in the second quarter of 2021 – widely linked to a multi-faceted regulatory crackdown on the sector – was to some extent counterbalanced by record levels of activity in India and Southeast Asia.
Sherpa Healthcare leads Series A for Paq Therapeutics
Sherpa Healthcare Partners has led a $30 million Series A for Paq Therapeutics, a Chinese-founded biotech company specializing in treatments based on molecules that enhance the degradation of disease-causing entities.
Carlyle leads $100m Series D for Chinese lingerie brand
Chinese lingerie brand Neiwai has raised a $100 million Series D round led by The Carlyle Group. Vertex Ventures China and Qiming Venture Partners re-upped.
GGV, Tiger Global lead $50m round for China bakery brand
Tiger Attitude, a China-based bakery brand, has raised a $50 million Series A round led by GGV Capital and Tiger Global. Both IDG Capital and Sequoia Capital China re-upped, having participated in a pre-Series A in January alongside Challenjers Capital.
China drug developer Adlai Nortye gets $100m Series D
Adlai Nortye, a Chinese biopharma player specializing in cancer treatments, has raised $100 million in Series D funding.
Boyu stands out in weak quarter for private equity fundraising
A quickfire fundraise by Boyu Capital – which saw $6 billion collected across two pools of capital in the space of a few months – accounted for more than one-quarter of all capital committed to Asia-focused private equity managers between April and...
Deal focus: Hefu does dining at scale
China restaurant chain Hefu Noodle caters to a lunchtime office-worker client base from a network of central kitchens. Meridian Capital is one of several investors sold on the expansion opportunity
Deal focus: Investcorp bides its time with Linkedcare
The GP spent six months scrutinizing China’s Linkedcare prior to leading a $70 million round, confident that its global insights into software, healthcare, and supply chains were key differentiators
2Q analysis: Trouble in China
Efforts to rein in China’s technology giants have dampened investor sentiment, with India and Southeast Asia stepping into the void. China remains active for fundraising, but there are fears that US IPO activity could take a hit
Regulator blocks China live-streaming platform merger
China’s antitrust watchdog has blocked a merger of Huya and Douyu - the country's two largest video game live-streaming platforms - initiated by Tencent Holdings.
IDG leads $77m round for China health-tech player Synyi
Synyi.AI - a Chinese provider of artificial intelligence-enabled medical services - has raised RMB500 million ($77 million) in Series E funding led by IDG Capital.
China community group buying platform Tongcheng Life goes bust
Tongcheng Life, a China-based community group buying business incubated by online travel agency Tongcheng-Elong, has announced its bankruptcy, blaming "poor management."
CMC leads $123m Series E for China noodle shop chain
CMC Capital has led a Series E funding round of nearly RMB800 million ($123 million) for Hefu Noodle, a Chinese noodle restaurant chain.
China's Crystal Stream backs Egypt e-commerce platform
Chinese VC firm Crystal Stream Capital has doubled down on a Middle East and Africa strategy with participation in a $40 million investment in Egyptian logistics start-up MaxAB.
China CRO player raises $50m to support US merger
DMed-Clinipace, a global contract research organization (CRO) with a presence in China, has raised $50 million in an extended Series C round led by Springhill Fund. Rock Springs Capital and Superstring Capital also took part.